

Brookfield vs CME Group
Large global asset manager owning real estate and infrastructure vs Global futures and options exchange operator with clearing services. Which is the better buy for your portfolio in October 2026? Plain-English answer below.
Brookfield Asset Management runs a global alternative investment platform managing hundreds of billions across infrastructure, real estate, credit, and private equity, growing fee-related earnings as successive flagship funds raise capital from institutions and wealth channels worldwide, while CME Group operates the world's largest derivatives exchange, generating nearly risk-free transaction fee income as traders hedge interest rates, commodities, energy, and equity indices around the clock. Both companies earn from deploying and intermediating vast pools of institutional capital through scaled platforms where network effects create durable barriers to competition. Brookfield vs CME Group explores how a capital-raising and long-duration asset deployment machine compares to a high-margin volume-driven exchange utility, letting readers assess fee durability, capital reinvestment requirements, and the different ways network effects compound into shareholder value.
Brookfield Asset Management runs a global alternative investment platform managing hundreds of billions across infrastructure, real estate, credit, and private equity, growing fee-related earnings as ...
Why It’s Moving

Brookfield Closes $2 Billion Asset-Backed Finance Fund Amid Stock Volatility
- Oaktree’s Asset-Backed Finance Fund achieved its target raise with $2 billion in commitments from global institutional investors, including U.S. public pension plans and sovereign wealth funds.
- BN shares have declined for seven consecutive weeks, reaching their lowest level since May of last year as the alternative investing sector faces headwinds.
- Despite the price drop, Brookfield is viewed as a capital-allocation powerhouse with a 127-year track record, trading at a perceived discount to intrinsic value while targeting core earnings doubling over five years.

CME Group Expands Derivatives Suite with New Crypto and Equity Futures
- CME will launch Bitcoin Cash (BCH) and Uniswap (UNI) futures on October 19, pending regulatory review, expanding its crypto derivatives suite.
- The exchange introduced new equity factor futures designed to offer institutions targeted exposure, margin offsets, and flexible trading options.
- The announcement coincided with significant price surges in the underlying assets, with Bitcoin Cash rising 21% following the news.

Brookfield Closes $2 Billion Asset-Backed Finance Fund Amid Stock Volatility
- Oaktree’s Asset-Backed Finance Fund achieved its target raise with $2 billion in commitments from global institutional investors, including U.S. public pension plans and sovereign wealth funds.
- BN shares have declined for seven consecutive weeks, reaching their lowest level since May of last year as the alternative investing sector faces headwinds.
- Despite the price drop, Brookfield is viewed as a capital-allocation powerhouse with a 127-year track record, trading at a perceived discount to intrinsic value while targeting core earnings doubling over five years.

CME Group Expands Derivatives Suite with New Crypto and Equity Futures
- CME will launch Bitcoin Cash (BCH) and Uniswap (UNI) futures on October 19, pending regulatory review, expanding its crypto derivatives suite.
- The exchange introduced new equity factor futures designed to offer institutions targeted exposure, margin offsets, and flexible trading options.
- The announcement coincided with significant price surges in the underlying assets, with Bitcoin Cash rising 21% following the news.
Investment Analysis
Pros
- Brookfield Corp benefits from diversified, long-duration real asset exposure across infrastructure, renewables, real estate, and private equity, providing resilience to economic cycles.
- The company’s global scale and presence in multiple high-growth geographies enable access to proprietary deal flow and sizeable investment opportunities not available to smaller competitors.
- Strong institutional partnerships and substantial third-party capital under management generate recurring, high-margin asset management fees and reduce dependence on balance sheet leverage.
Considerations
- Brookfield’s elevated leverage and debt-to-equity ratio increase sensitivity to rising interest rates and refinancing risks in volatile credit markets.
- Complex corporate structure and multiple subsidiaries create challenges in transparency, governance, and consistent investor communication.
- Exposure to illiquid, long-term real assets may result in valuation volatility and limited flexibility during periods of market stress or liquidity contraction.

CME Group
CME
Pros
- CME Group operates the world’s largest and most liquid derivatives marketplace, with a near-monopoly position in key global benchmark products for interest rates, equity indices, commodities, and FX.
- The business model is highly scalable and cash-generative, driven by high-margin electronic trading, recurring clearing revenues, and minimal operational leverage in a largely fixed-cost infrastructure.
- Global regulatory emphasis on central clearing and risk management supports long-term structural growth in demand for CME’s core products and services.
Considerations
- CME Group’s earnings are sensitive to trading volumes, which can fluctuate significantly with macro volatility, interest rate cycles, and investor risk appetite.
- The company faces increasing competition from alternative trading venues, regional exchanges, and over-the-counter markets, which may erode pricing power over time.
- Regulatory changes or shifts in clearing mandates could disrupt business flows, while market structure reforms may reduce the profitability of certain legacy products.
Brookfield (BN) Next Earnings Date
No confirmed upcoming earnings date has been announced for BN as of the current reporting cycle. Based on the historical pattern where reports typically occur approximately three months after the prior release, the next expected timing is late October 2026. This anticipated report will cover the third quarter of fiscal year 2026. Investors should monitor official channels for confirmation of this projected schedule.
CME Group (CME) Next Earnings Date
CME Group is scheduled to release its next earnings report on October 21, 2026, before the market opens. This upcoming disclosure will cover financial results for the third quarter of 2026. The confirmed date aligns with the company's historical pattern of reporting approximately three months after the previous quarter-end.
Brookfield (BN) Next Earnings Date
No confirmed upcoming earnings date has been announced for BN as of the current reporting cycle. Based on the historical pattern where reports typically occur approximately three months after the prior release, the next expected timing is late October 2026. This anticipated report will cover the third quarter of fiscal year 2026. Investors should monitor official channels for confirmation of this projected schedule.
CME Group (CME) Next Earnings Date
CME Group is scheduled to release its next earnings report on October 21, 2026, before the market opens. This upcoming disclosure will cover financial results for the third quarter of 2026. The confirmed date aligns with the company's historical pattern of reporting approximately three months after the previous quarter-end.
Buy BN or CME in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


